Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Science

• Publication date

  2001-08-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1126/SCIENCE.1061620PMID 11533494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation.

  2009cited by this paper
• Prevention of fat-induced insulin resistance by salicylate.

  2001cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling

  2000cited by this paper
• The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

  2000cited by this paper
• PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

  2000cited by this paper
• PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.

  2000cited by this paper
• Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene

  1999cited by this paper
• The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis

  1999cited by this paper
• Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

  1999cited by this paper
• Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.

  1999cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

  1998cited by this paper
• The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta.

  1998cited by this paper
• Is Type II diabetes mellitus a disease of the innate immune system?

  1998cited by this paper
• A Molecular Basis for Insulin Resistance

  1997cited by this paper
• A cytokine-responsive IκB kinase that activates the transcription factor NF-κB

  1997cited by this paper
• The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.

  1997cited by this paper
• The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation

  1997cited by this paper
• A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.

  1997cited by this paper
• The serine/threonine phosphatase inhibitor calyculin A induces rapid degradation of IkappaBbeta. Requirement of both the N- and C-terminal sequences.

  1997cited by this paper
• The Serine/Threonine Phosphatase Inhibitor Calyculin A Induces Rapid Degradation of IκBβ

  1997cited by this paper
• Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.

  1995cited by this paper
• Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.

  1994cited by this paper
• Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs.

  1994cited by this paper
• Are There Differences Among Nonsteroidal Antiinflammatory Drugs

  1994cited by this paper
• Inhibition of NF-kappa B by sodium salicylate and aspirin.

  1994cited by this paper
• Okadaic acid, insulin, and denervation effects on glucose and amino acid transport and glycogen synthesis in muscle.

  1993cited by this paper
• Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

  1993cited by this paper
• Ezrin-calpain I interactions in gastric parietal cells.

  1993cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

  1992cited by this paper
• Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes.

  1989cited by this paper
• Salicylates as Hypoglycemic Agents

  1982cited by this paper
• The Influence of Salicylate on Hyperglycemia

  1960cited by this paper
• Aspirin and Diabetes Mellitus

  1957cited by this paper
• On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

  1901cited by this paper

• Immunometabolism in obesity: Understanding the beneficial and detrimental roles of inflammation

  2026cites this paper
• Modulation of endoplasmic reticulum stress–induced insulin resistance by the low-carbohydrate high-fat ketogenic diet

  2026cites this paper
• From Painkillers to Antidiabetics: Structural Modification of NSAID Scaffolds for Drug Repurposing

  2026cites this paper
• The Interplay Between Reactive Oxygen Species, Glucose Metabolism and NF-kB in the Pathogenesis of Type 2 Diabetes

  2026cites this paper
• Effects of Modified Messenger RNA of Adiponectin Delivered by Lipid Nanoparticles on Adipogenesis and Bone Metabolism In Vitro and In Vivo

  2025cites this paper
• NF-κB: master regulator of cellular responses in health and disease

  2025cites this paper
• Cyanidin-3-glucoside: targeting atherosclerosis through gut microbiota and anti-inflammation

  2025cites this paper
• Association of Triglyceride-Glucose (TyG) Index With Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis

  2025cites this paper
• Association between polycyclic aromatic hydrocarbons (PAHs) and insulin resistance: A comprehensive study utilizing NHANES data and network toxicology.

  2025cites this paper
• Beneficial effects of long-chain n-3 fatty acids on insulin-resistance: basic and clinical aspects.

  2025cites this paper
• From Lipids to Glucose: Investigating the Role of Dyslipidemia in the Risk of Insulin Resistance.

  2025cites this paper
• The Ancient Drug Salicylate Indirectly Targets Fructose‐1,6‐Bisphosphatase to Suppress Liver Glucose Production in Diet‐Induced Obese Mice

  2025cites this paper
• Temporal dynamics of IgG-mediated immunometabolic dysfunction: from acute obesity to chronic aging

  2025cites this paper
• Paternal Microplastic Exposure Alters Sperm Small Noncoding RNAs and Affects Offspring Metabolic Health in Mice

  2025cites this paper
• Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

  2025cites this paper
• Farnesoid X Receptor (FXR) Agonists and Protein Kinase Regulation in NAFLD and NASH: Mechanisms and Therapeutic Potential

  2025cites this paper
• Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms–a comprehensive review

  2025cites this paper
• An update on the role of inflammation in insulin resistance and islet β cell failure- A crosstalk between immune cells, adipose tissue, cytokines, and oxidative stress

  2025cites this paper
• Immunometabolism in cancer: a systemic perspective

  2025cites this paper
• Macrophages: friend or foe in diabetes pathogenesis and therapy

  2025cites this paper
• Cardiac Aging: Molecular Mechanisms and Therapeutic Interventions.

  2025cites this paper
• Siglec-E deletion alters AT macrophages phenotypes, induces an inflammatory response, and adipogenesis during diet-induced obesity.

  2025cites this paper
• Adipose tissue NLRP3 inflammasome: a therapeutic target in obesity and type 2 diabetes mellitus.

  2025cites this paper
• Krill Oil Reverses White Adipose Tissue Dysfunction by Inhibiting Macrophage M1 Polarization in Mice With Type 2 Diabetes

  2025cites this paper
• NF-κB in inflammation and cancer

  2025cites this paper
• 14-Deoxy-11,12-didehydroandrographolide Alleviates IL-1β-Induced Insulin Resistance by Modulating NOX2-Driven ROS Generation and Restoring Insulin Signaling in 3T3-L1 Adipocytes

  2025cites this paper
• Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells

  2025cites this paper
• Empagliflozin Downregulates AMP‐Activated Protein Kinaseα O‐GlcNAcylation to Ameliorate Hepatic Steatosis

  2025cites this paper
• Pathophysiologic interrelationships of metabolic syndrome and gut microbiota

  2025cites this paper
• A Review on Comorbidity of Diabetes Mellitus

  2025cites this paper
• Cultural and Molecular Factors Predisposed to Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

  2025cites this paper
• Effects of soleus muscle push-ups on oxidative stress, inflammatory markers and adipocytokines. A scoping review

  2025cites this paper
• Review: Shilajit (Mumie) A natural Product with Anti-hyperglycemic, Anti-obesity, Anti-oxidant, and Anti-Inflammatory properties for a potential treatment of diabetes mellitus

  2024cites this paper
• Inflammatory mediator contributes to leptin resistance and obesity in craniopharyngioma

  2024cites this paper
• Protein Kinases in Obesity, and the Kinase-Targeted Therapy.

  2024cites this paper
• Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment

  2024cites this paper
• AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure.

  2024cites this paper
• Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study.

  2024cites this paper
• The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target

  2024cites this paper
• Insulin Resistance, Obesity, and Lipotoxicity.

  2024cites this paper
• Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome.

  2024cites this paper
• Ginkgolide B alleviates glucolipid metabolism disorders and adipose tissue inflammation by inhibiting thromboxane A2 synthesis

  2024cites this paper
• Pharmacokinetic Profile and Comparative Bioavailability of an Oral Fixed‐Dose Combination of Metformin and Acetylsalicylic Acid (Aspirin)

  2024cites this paper
• Mechanisms of insulin resistance in type 1 diabetes mellitus: A case of glucolipotoxicity in skeletal muscle

  2024cites this paper
• Salicylate induces epithelial actin reorganization via activation of the AMP-activated protein kinase and promotes wound healing and contraction in mice

  2024cites this paper
• Pantothenic Acid Alleviates Fat Deposition and Inflammation by Suppressing the JNK/P38 MAPK Signaling Pathway

  2024cites this paper
• Surprising magic of CD24 beyond cancer

  2024cites this paper
• Orchestration of the Adipose Tissue Immune Landscape by Adipocytes.

  2024cites this paper
• Effects of Low and High Doses of Aspirin on Inflammatory Markers in Diabesity Patients: A Quasi-Experimental Study

  2024cites this paper
• Effect of the ketone beta-hydroxybutyrate on markers of inflammation and immune function in adults with type 2 diabetes.

  2024cites this paper
• Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis

  2024cites this paper
• Allyl isothiocyanate, A TRPA1 agonist, protects against olanzapine-induced hypothalamic and hepatic metabolic aberrations in female mice.

  2024cites this paper
• Natural Products and Diabetes: (-)-Epicatechin and Mechanisms Involved in the Regulation of Insulin Sensitivity.

  2024cites this paper
• Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1/PI3K/AKT and NF-κB signaling pathways.

  2024cites this paper
• Triptolide Administration Alters Immune Responses to Mitigate Insulin Resistance in Obese States

  2024cites this paper
• Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression

  2023cites this paper
• Physical Activity as a Modern Intervention in the Fight against Obesity-Related Inflammation in Type 2 Diabetes Mellitus and Gestational Diabetes

  2023cites this paper
• A nitroalkene derivative of salicylate alleviates diet-induced obesity by activating creatine metabolism and non-shivering thermogenesis

  2023cites this paper
• IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors

  2023cites this paper
• Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease

  2023cites this paper
• What’s gut got to do with it? The role of the microbiota and inflammation in the development of adiposity and obesity

  2023cites this paper
• Prophylactic consequences of sodium salicylate nanoparticles in cisplatin-mediated hepatotoxicity

  2023cites this paper
• Role of obesity related inflammation in pathogenesis of peripheral artery disease in patients of type 2 diabetes mellitus

  2023cites this paper
• Deoxysphingolipids - atypical skeletal muscle lipids related to insulin resistance in humans that decrease insulin sensitivity in vitro.

  2023cites this paper
• Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model

  2023cites this paper
• Insights into the development of insulin resistance: Unraveling the interaction of physical inactivity, lipid metabolism and mitochondrial biology

  2023influential citation
• An Evaluation of the Anti-Inflammatory Effects of a Thai Traditional Polyherbal Recipe TPDM6315 in LPS-Induced RAW264.7 Macrophages and TNF-α-Induced 3T3-L1 Adipocytes

  2023cites this paper
• Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications

  2023cites this paper
• The PTGS2/COX2-PGE2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus

  2023cites this paper
• Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus

  2023cites this paper
• Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy

  2023cites this paper
• The crucial role and mechanism of insulin resistance in metabolic disease

  2023cites this paper
• Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes

  2023cites this paper
• A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease.

  2023cites this paper
• Aspirin suppresses hepatic glucagon signaling through decreasing production of thromboxane A2.

  2023cites this paper
• RELA governs a network of islet-specific metabolic genes necessary for beta cell function

  2023cites this paper
• Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis

  2023cites this paper
• Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs

  2023cites this paper
• Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia.

  2023cites this paper
• Non-Genetic-Induced Zebrafish Model for Type 2 Diabetes with Emphasis on Tools in Model Validation

  2023cites this paper
• Modular characteristics and mechanism of action of herbs for type 2 diabetes treatment in Chinese medicine

  2023cites this paper
• Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non‐alcoholic fatty liver disease

  2023cites this paper
• Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases

  2023cites this paper
• A review: Mechanism and prospect of gastrodin in prevention and treatment of T2DM and COVID-19

  2023cites this paper
• The stress-responsive protein REDD1 and its pathophysiological functions

  2023cites this paper
• The pathophysiology of MASLD: an immunometabolic perspective

  2023cites this paper
• Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review

  2023cites this paper
• Treatment with Gut-Specific Nonsteroidal Anti-Inflammatory Drug Attenuates Metabolic Inflammation but not Body Mass in Fattening Ground Squirrels.

  2023cites this paper
• Inflammation in obesity, diabetes, and related disorders.

  2022cites this paper
• Effects of a single transdermal administration of flunixin meglumine in early postpartum Holstein Friesian dairy cows: Part 1. Inflammatory and metabolic markers, uterine health, and indicators of pain.

  2022cites this paper
• Insulin: The master regulator of glucose metabolism.

  2022cites this paper
• An enriched environment re-establishes metabolic homeostasis by reducing obesity-induced inflammation

  2022cites this paper
• Insights on the role of anti-inflammatory and immunosuppressive agents in the amelioration of diabetes

  2022cites this paper
• The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review

  2022cites this paper
• The Role of Catechins in Regulating Diabetes: An Update Review

  2022cites this paper
• Anthocyanins as Promising Molecules Affecting Energy Homeostasis, Inflammation, and Gut Microbiota in Type 2 Diabetes with Special Reference to Impact of Acylation

  2022cites this paper
• Advances in “adiponcosis”: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay

  2022cites this paper
• Role of mitochondria-associated endoplasmic reticulum membranes in insulin sensitivity, energy metabolism, and contraction of skeletal muscle

  2022cites this paper
• Cell death and inflammation during obesity: “Know my methods, WAT(son)”

  2022cites this paper
• The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK

  2022cites this paper